Skip to main content
SpringerLink
Log in

Colorectal Cancer Imaging

  • Chapter
Book cover Colorectal Cancer

Part of the book series: Current Clinical Oncology ((CCO))

  • 823 Accesses

Abstract

Imaging of the colorectal cancer patient is employed in three basic settings: evaluation of extent of disease in the preoperative patient, evaluation of the presence or absence of recurrence in the surgically cured patient, and evaluation of the response or progression of disease in the patient with known metastatic cancer. This chapter explores the role of different imaging modalities in each of these scenarios.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Megibow AJ, Balthazar EJ, Cho KC, Medwid SW, Birnbaum BA, Noz ME. Bowel obstruction: evaluation with CT. Radiology 1991;180(2):313–318.

    PubMed  CAS  Google Scholar 

  2. Zerhouni EA, Rutter C, Hamilton SR, et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 1996; 200(2):443–451.

    PubMed  CAS  Google Scholar 

  3. Mehta S, Johnson RJ, Schofield PF. Staging of colorectal cancer. Clin Radiol 1994;49(8):515–523.

    Article  PubMed  CAS  Google Scholar 

  4. Coakley FV, Hricak H. Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol 1999;54(9):563–574.

    Article  PubMed  CAS  Google Scholar 

  5. Truant S, Huglo D, Hebbar M, Ernst O, Steinling M, Pruvot FR. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 2005;92(3):362–369.

    Article  PubMed  CAS  Google Scholar 

  6. Peterson MS, Baron RL, Dodd GD III, et al. Hepatic parenchymal perfusion defects detected with CTAP: imaging-pathologic correlation. Radiology 1992;185(1):149–155.

    PubMed  CAS  Google Scholar 

  7. Khalil HI, Patterson SA, Panicek DM. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 2005;235(3):872–878.

    Article  PubMed  Google Scholar 

  8. Kroncke TJ, Taupitz M, Kivelitz D, et al. Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur Radiol 2000;10(7):1095–1100.

    Article  PubMed  CAS  Google Scholar 

  9. Sahani DV, Krishnamurthy SK, Kalva S, et al. Multidetector-row computed tomography angiography for planning intra-arterial chemotherapy pump placement in patients with colorectal metastases to the liver. J Comput Assist Tomogr 2004;28(4):478–484.

    Article  PubMed  Google Scholar 

  10. Brown, GHJ. Colorectal cancer. Imaging in Oncology (Husband JE, Resnek RH, eds.) Isis Medical Media: Oxford, England. 2004; pp. 217–243.

    Google Scholar 

  11. Blomqvist L, Holm T, Rubio C, Hindmarsh T. Rectal tumours—MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections. A comparative study. Acta Radiol 1997;38(3):437–444.

    Article  PubMed  CAS  Google Scholar 

  12. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003;227(2):371–377.

    Article  PubMed  Google Scholar 

  13. Beets-Tan RG, Beets GL, Vliegen RF, et al., Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357(9255):497–504.

    Article  PubMed  CAS  Google Scholar 

  14. Bartolozzi C, Donati F, Cioni D, et al. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 2004;14(1):14–20.

    Article  PubMed  Google Scholar 

  15. Valk PE, Abella-Columna E, Haseman MK, et al. Whole-body PET imaging with [18F] fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999;134(5):503–511; discussion 511-513.

    Article  PubMed  CAS  Google Scholar 

  16. Blomqvist L, Brown G. Colorectal cancer imaging. AJR Am J Roentgenol 2004;182(6):1600–1601.

    PubMed  Google Scholar 

  17. Heald RJ. Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br J Surg 1995;82(10):1297–1299.

    Article  PubMed  CAS  Google Scholar 

  18. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):848-857.

    Article  Google Scholar 

  19. Heald RJ, Karanjia ND. Results of radical surgery for rectal cancer. World J Surg 1992;16(5):848–857.

    Article  PubMed  CAS  Google Scholar 

  20. Freeny PC, Marks WM, Ryan JA, Bolen JW. Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence. Radiology 1986;158(2):347–353.

    PubMed  CAS  Google Scholar 

  21. Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004;22(8):1420–1429.

    Article  PubMed  CAS  Google Scholar 

  22. Johnson FE, Virgo KS, Fossati R. Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol 2004;22(8):1363–1365.

    Article  PubMed  Google Scholar 

  23. Imbriaco M, Akhurst T, Hilton S, et al. Whole-body FDG-PET in patients with recurrent colorectal carcinoma. A comparative study with CT. Clin Positron Imaging 2000;3(3):107–114.

    Article  PubMed  Google Scholar 

  24. Kalff VV, Hicks R, Ware R, Binns D, McKenzie A. F-18 FDG PET for suspected or confirmed regional recurrence of colon cancer. A prospective study of impact and outcome. Clin Positron Imaging 2000;3(4):183.

    Article  PubMed  Google Scholar 

  25. Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000;41(7):1177–1189.

    PubMed  CAS  Google Scholar 

  26. Luccichenti G, Cademartiri F, Sianesi M, Roncoroni L, Pavone P, Krestin GP. Radiologic assessment of rectosigmoid cancer before and after neoadjuvant radiation therapy: comparison between quantitation techniques. AJR Am J Roentgenol 2005;184(2):526–530.

    PubMed  Google Scholar 

  27. Morgan B, Thomas AL, Drevs J, et al., Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 2003;21(21):3955–3964.

    Article  PubMed  CAS  Google Scholar 

  28. Liu G, Rugo HS, Wilding G, et al. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. J Clin Oncol 2005;23(24):5464–5473.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY

    Sean D. Curran FFR, RCSI & Laurence H. Schwartz MD

Authors
  1. Sean D. Curran FFR, RCSI
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laurence H. Schwartz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY

    Leonard B. Saltz MD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Curran, S.D., Schwartz, L.H. (2007). Colorectal Cancer Imaging. In: Markman, M., Saltz, L.B. (eds) Colorectal Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-215-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-215-1_12

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-751-8

  • Online ISBN: 978-1-59745-215-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation